Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Lacosamide Monotherapy Follow-up in Epilepsy
NCT02582866Phase 3Completed
- Sponsor
- UCB
- Start
- Jan 2016
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of lacosamide in epilepsy, sponsored by UCB. Started Jan 2016; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02582866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02582866.